A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV -- short for respiratory syncytial virus -- vaccine.
Regenstrief InstituteOct 18 2024 VISION Network researchers report that across the board these vaccines were highly effective in older adults, even those with immunocompromising conditions, during the 2023-24 respiratory disease season, the first season after RSV vaccine approval in the U.S.
The study was a collaboration among the Centers for Disease Control and Prevention and geographically diverse U.S. healthcare systems and research centers with integrated medical, laboratory and vaccination records – all members of the CDC's VISION Network. In the U.S., respiratory disease season typically commences in late September or early October and continues through March or early April.
"No vaccine is 100 percent effective. An 80 percent vaccine effectiveness rate is quite impressive and higher than we see, for example, with the influenza vaccine," said study co-author Brian Dixon, PhD, MPA. "The bottom line is that using real world data from electronic medical records routinely captured in care for people from diverse walks of life we found that having the vaccine was highly protective against hospitalization, severe illness and death." Dr.
Healthcare Intensive Care Laboratory Medicine MPA Public Health Research Respiratory Respiratory Disease Respiratory Syncytial Virus Virus
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Vaccinate NOW to avoid ‘tripledemic’ of viruses, warn NHS chiefs as millions offered new jabWhat is RSV (Respiratory Syncytial Virus) or bronchiolitis?
Read more »
Vaccine push amid Fears of a 'tripledemic' of Covid, flu, and RSVWinter 2024 could see a 'tripledemic' which could overwhelm the UK, so the NHS is urging those eligible for Covid and flu jabs to get vaccinated.
Read more »
Millions urged to book new jab that prevents killer lung infection today or risk deathWhat is RSV (Respiratory Syncytial Virus) or bronchiolitis?
Read more »
Older people should take a new vaccine to protect them against respiratory syncytial virus (RSV)Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research from the University of Aberdeen and the MRC-University of Glasgow Center for Virus Research.
Read more »
Ziresovir reduces signs, symptoms of bronchiolitis in babies with RSVFor infants and young children hospitalized with respiratory syncytial virus (RSV) infection, ziresovir reduces signs and symptoms of bronchiolitis, according to a study published in the Sept. 26 issue of the New England Journal of Medicine.
Read more »
Everything NHS has said about 'tripledemic' and what people should doThe RSV, flu and Covid viruses are doing the rounds
Read more »